サインイン

De Zeng

Department of Medical Oncology

Cancer Hospital of Shantou University Medical College

BIOGRAPHY

De Zeng has not added Biography.

If you are De Zeng and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway.

Cancer management and research , 2019 | Pubmed ID: 30613163

Use of clinical nomograms for predicting survival outcomes in young women with breast cancer.

Oncology letters Feb, 2019 | Pubmed ID: 30675206

is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma.

Cancer management and research , 2019 | Pubmed ID: 30881130

INSTITUTIONS

Cancer Hospital of Shantou University Medical College

JOVE ARTICLES

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Min-na Chen¹,

De Zeng²,

Zhuo-qun Zheng³,

Zheng Li³,

Jian-le Wu³,

Jun-yu Jin³,

He-jia Wang³,

Cui-zhen Huang¹,

Hao-yu Lin¹

¹Department of Thyroid and Breast Surgery, First Affiliated Hospital of Shantou University Medical College,

²Department of Medical Oncology, Cancer Hospital of Shantou University Medical College,

³, Shantou University Medical College

Cancer Research

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center

De Zeng

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Medical Oncology

Cancer Hospital of Shantou University Medical College

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Department of Medical Oncology